PHILADELPHIA and LONDON, July 16 Since January 2009, MediciGlobal has received a record number of national and international awards for its work in patient education and design. In June, 2009 MediciGlobal announced that it was the recipient of four 2009 Communicator Awards from the International Academy of the Visual Arts for various programmes. On July 9th, the company was further notified of six more awards (two silver, and two bronze) from the 16th Annual National Health Information Awards and two bronze awards from The 26th Annual Healthcare Advertising Awards. These awards all honour the best examples of creative healthcare information, programmes and materials for consumers.
MediciGlobal, a leading company in the development of patient recruitment, retention and education programmes for clinical trials, won its awards on behalf of five global pharmaceutical clients. The programmes covered a range of medical conditions including: depression, preterm pregnancy, restless leg syndrome, menopause, clinically isolated syndrome (CIS); pre-diagnosed Multiple Sclerosis, and teen migraine.
From 2007, MediciGlobal has received a total of 16 national and international awards for its patient recruitment and retention programmes. "This broad recognition demonstrates the quality and importance of our work. Our team develops patient-focused programmes that are innovative, adhere to health literacy guidelines and deliver results," said Liz Moench, MediciGlobal's President and CEO.
"Beyond these awards however, the best mark of success and recognition comes with their use." Moench adds. "Our programmes are successful when they help patients with their decision-making, such as joining a clinical trial, and when research staff finds them supportive in explaining study details to patients and families."
MediciGlobal based in the U.S. and U.K., is a specialty patient recruitment - retention company, developing patient-centric programmes for clinical trials of all sizes, and in countries around the globe. MediciGlobal's patient recruitment and retention programmes ensure that biopharmaceutical and life sciences companies accelerate the enrolment process for clinical trials. MediciGlobal is one of few companies focused solely on patient recruitment and retention for almost two decades. www.mediciglobal.com